Dana-Farber posts $54.3M operating income in 1st half of 2023

Boston-based Dana-Farber Cancer Institute has reported a $54.3 million operating income for the six months ending March 31.

Advertisement

That figure was on par with the previous fiscal year’s operating income of $54.7 million for the same period. The stable operating income figure was achieved despite operating expenses of $1.4 billion rising $197.2 million, or 16.4 percent, over the first six months of fiscal year 2022.

Total operating revenue for the first six months of fiscal 2023 was approximately $1.5 billion, an increase of $196.9 million, or 15.7 percent, over the same period in 2022.

Overall income for the system totaled $110.3 million in the six-month period.

The system, in addition to its two main campuses, operates six other centers in Massachusetts and New Hampshire.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.